Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation
Condition(s):Oral ContraceptiveLast Updated:September 10, 2014Unknown status
Hide Studies Not Open or Pending
Condition(s):Oral ContraceptiveLast Updated:September 10, 2014Unknown status
Condition(s):Oral ContraceptiveLast Updated:February 23, 2018Completed
Condition(s):Rheumatoid ArthritisLast Updated:April 1, 2013Completed
Condition(s):Ovarian Cancer Risk; Risk-reducing Surgery; Fallopian Tube Fimbriae; Ovarian Cortical Inclusion CystsLast Updated:June 25, 2020Completed
Condition(s):HealthyLast Updated:December 2, 2009Completed
Condition(s):Solid CancersLast Updated:June 29, 2015Completed
Condition(s):PharmacokineticsLast Updated:January 5, 2010Completed
Condition(s):HIV Infections; PregnancyLast Updated:November 1, 2021Completed
Condition(s):CancerLast Updated:January 26, 2016Withdrawn
Condition(s):HealthyLast Updated:August 25, 2009Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.